loadpatents
name:-0.00041007995605469
name:-0.02292013168335
name:-0.00049185752868652
Wachtel; Helmut Patent Filings

Wachtel; Helmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wachtel; Helmut.The latest application filed is for "chiral methylphenyloxazolidinones".

Company Profile
0.22.0
  • Wachtel; Helmut - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chiral methylphenyloxazolidinones
Grant 6,025,376 - Laurent , et al. February 15, 2
2000-02-15
Chiral phenyldihydrofuranones as PDE-IV inhibitors
Grant 6,011,060 - Laurent , et al. January 4, 2
2000-01-04
N-(8.alpha.-ergolinyl)-amides
Grant 5,547,958 - Sauer , et al. August 20, 1
1996-08-20
2, 13-disubstituted ergolines, their production and use in pharmaceutical agents
Grant 5,411,966 - Sauer , et al. May 2, 1
1995-05-02
2,14-disubstituted ergolines, their production and use in pharmaceutical compositions
Grant 5,401,748 - Sauer , et al. March 28, 1
1995-03-28
8.alpha.-acylamino ergolines and use as pharmaceutical agents
Grant 5,212,178 - Sauer , et al. May 18, 1
1993-05-18
2-substituted ergolines
Grant 5,158,957 - Brumby , et al. * October 27, 1
1992-10-27
3,4-disubstituted phenyl heterocycles and their use
Grant 5,064,854 - Huth , et al. November 12, 1
1991-11-12
1,2-disubstituted ergolines useful for producing central antidopanminergic or .alpha.2-receptor-blocking activity
Grant 4,874,768 - Huth , et al. October 17, 1
1989-10-17
12- and 13-substituted ergoline derivatives having alpha.sub.2 -receptor-blocking effect
Grant 4,863,929 - Sauer , et al. * September 5, 1
1989-09-05
2-substituted ergolines having neuroleptic and antidepressant activities
Grant 4,847,262 - Sauer , et al. July 11, 1
1989-07-11
1-alkyl ergolinylthiourea derivatives and their use as antidepressant agents
Grant 4,772,610 - Biere , et al. September 20, 1
1988-09-20
Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents
Grant 4,766,128 - Sauer , et al. August 23, 1
1988-08-23
2-substituted ergolines useful as neuroleptics and antidepressants
Grant 4,731,367 - Sauer , et al. March 15, 1
1988-03-15
Terguride as antihypertensive
Grant 4,593,032 - Kehr , et al. June 3, 1
1986-06-03
Trans-dihydrolisuride antipsychotic
Grant 4,522,820 - Dorow , et al. June 11, 1
1985-06-11
4-(Polyalkoxy phenyl)-2-pyrrolidones
Grant 4,193,926 - Schmiechen , et al. March 18, 1
1980-03-18
5-(Substituted phenyl)-oxazolidinones and their sulfur analogs
Grant 4,186,129 - Huth , et al. January 29, 1
1980-01-29
4-(Polyalkoxyphenyl)-2-pyrrolidones (II)
Grant 4,153,713 - Huth , et al. May 8, 1
1979-05-08
18-Methyl-19-nor-20-ketopregnanes and process for the preparation thereof
Grant 4,029,777 - Engelfried , et al. June 14, 1
1977-06-14
Benzomorphan derivatives
Grant 4,020,164 - Rahtz , et al. April 26, 1
1977-04-26
4-(Polyalkoxyphenyl)-2-pyrrolidones
Grant 4,012,495 - Schmiechen , et al. March 15, 1
1977-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed